Back to
Mitsubishi UFJ Asset Management Co., Ltd.
CRSP
Showing 8 of 31 quarters
Position history for
Mitsubishi UFJ Asset Management Co., Ltd.'s holdings in CRISPR THERAPEUTICS AG
Yes. Mitsubishi UFJ Asset Management holds 5,194 shares of CRSP (Crispr Therapeutics), worth $283,281, as of its Q2 2026 13F filing. It increased the position by 315 shares (+6.5%) from Q1 2026. Mitsubishi UFJ Asset Management has held CRSP in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$283,281
Current Shares
5,194
Total Value Change
+$54,019
Total Shares Change
+314
Quarter-by-Quarter History